Pharmacokinetic Study of DA-020

Starting soon · Early Phase 1

Conditions studied: Chemotherapy Induced Alopecia, Chemotherapy Side Effects

In brief

Pharmacokinetic Study of DA-020

Key facts

Study ID

NCT07402330

Run by

Applied Biology, Inc.

People needed

60

Starts

2026-04-16

Expected to finish

2026-11-30

Last updated by the study team

2026-04-13

Who can join

Age: 18 and older, up to 55. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Healthy females, age 18-55
• BMI: 18-30 kg/m²
• Fitzpatrick Skin Types I-IV (to standardize absorption risk)
• Scalp free from irritation, dermatologic disease, or damage
• Able to refrain from using other topical scalp products

You may not qualify if…

• History of cardiovascular disease, hypertension, or arrhythmia
• Scalp infections, wounds, or significant hair loss
• Recent use of medications that interfere with CYP enzymes or adrenergic systems
• Known sensitivity to phenylephrine or ethanol
• Positive drug screen or abnormal ECG at screening

Where it is running

• Hospital Samel — Manaus, Brazil
• University of Rome ("G. Marconi") — Rome, Italy

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.